dihexa approval status fda 10MG : COA Tested Research peptide Dihexa Peptide in Austin, TX

Pharmacokinetic studies demonstrated approximately 38% oral bioavailability and blood-brain barrier penetration, unusual for a peptide-based compound and attributable to Dihexa's small size (504.66 Da) and hydrophobic modifications

This is of significance since although corticosteroid use has long been and remains controversial for healing of tissues (Carrico et al

This is part of what makes peptides so appealing compared to typical pharmaceuticals: Many of the most common peptides used for medicinal purposes today (like for weight loss, diabetes, and hormone issues) are sequenced directly from peptides in our bodies

Mazzocchi A, et al